Selecta Biosciences
Utility Patents

Last updated:

List of all Selecta Biosciences patents 6 in total

Status Patent
Grant
Utility: Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity External link
Filling date: 6 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses External link
Filling date: 6 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen External link
Filling date: 6 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells External link
Filling date: 6 Sep 2025 Issue date: 15 Oct 2019
Grant
Utility: Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose External link
Filling date: 6 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells External link
Filling date: 6 Sep 2025 Issue date: 24 Sep 2019

Showing 1 to 6 of 6 patents.